Aurora Cannabis Inc

$3.00
Market Cap 170.13M
ROE -30.8%
Gross Margin 78.4%
Debt/Equity 0.0
Current Ratio 5.9
Revenue QoQ 5.1%
EPS QoQ 1.8%
F-Score 4

About

Aurora is a global leader in medical cannabis, dedicated to improving lives through scientific expertise, proven performance, and a deep commitment to patient care. Aurora serves medical markets across Canada, Europe, Australia, and New Zealand with a portfolio of trusted, leading brands including Aurora®, MedReleaf®, Pedanios®, IndiMed™, San Raf®, and Whistler Medical Marijuana Corporation®. With world-class GMP-certified manufacturing facilities in Canada and Germany, and a team of industry-leading professionals, Aurora continues to expand its global footprint and deliver consistent, high-quality cannabis products with the purpose of Opening the World to Cannabis™. Aurora's common shares trade on the NASDAQ and TSX under the symbol "ACB".

Exchange
NASDAQ
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Sector context

Healthcare

Undervalued

Trading at a discount to sector peers

P/E
-1.47
vs median 32.28
P/B
0.47
vs median 2.77
ROE
-0.31
vs median 0.12

Lower quality - review fundamentals carefully

Small-cap company with higher volatility

Similar companies

Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics